These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8127514)

  • 1. Control of high cost medicines.
    Jones SW
    N Z Med J; 1994 Mar; 107(974):113. PubMed ID: 8127514
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of high cost medicines.
    Hedley JM
    N Z Med J; 1994 Mar; 107(974):113. PubMed ID: 8127513
    [No Abstract]   [Full Text] [Related]  

  • 3. The economics of drug development: a grim reality and a role for clinical pharmacology.
    Honig P; Lalonde R
    Clin Pharmacol Ther; 2010 Mar; 87(3):247-51. PubMed ID: 20160740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Social pharmacology and drug overregulation].
    Alloza JL
    Med Clin (Barc); 2005 Mar; 124(10):379-82. PubMed ID: 15766510
    [No Abstract]   [Full Text] [Related]  

  • 5. How clinical is clinical pharmacology? Special consideration of clinical pharmacokinetics.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():9S-16S. PubMed ID: 7321664
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting rational use of medicines saves lives and money, WHO experts say.
    Saudi Med J; 2004 Sep; 25(9):1309-10. PubMed ID: 15559926
    [No Abstract]   [Full Text] [Related]  

  • 7. How are new medicines better medicines?
    Spencer PS
    J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():324-30. PubMed ID: 8098739
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface.
    Lawton G; Witty DR
    Prog Med Chem; 2008; 46():v-vi. PubMed ID: 18381122
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors to consider after cost-benefit analysis.
    Kubica AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1864, 1869, 1871. PubMed ID: 6816066
    [No Abstract]   [Full Text] [Related]  

  • 10. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Payers struggle to ensure high level of adherence to costly specialty drugs.
    Sipkoff M
    Manag Care; 2008 Jul; 17(7):24-6, 29, 31. PubMed ID: 18757021
    [No Abstract]   [Full Text] [Related]  

  • 12. Adolescent pharmacology: a pertinent issue of medicine as opposed to medicines.
    Kearns GL; Spaulding-Barclay M
    Clin Pharmacol Ther; 2008 Dec; 84(6):639-44. PubMed ID: 19008899
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines of the use of expensive medicines.
    Forgeson G
    N Z Med J; 1995 Mar; 108(996):111. PubMed ID: 7715879
    [No Abstract]   [Full Text] [Related]  

  • 14. Revised drug policy.
    Shelat AJ
    J Indian Med Assoc; 1995 Mar; 93(3):117-8. PubMed ID: 8522818
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 16. How to dramatically decrease your MCO'S Rx coverage costs.
    Cahn L
    Manag Care; 2008 Apr; 17(4):31-5. PubMed ID: 18464571
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology in health care, teaching and research.
    Rawlins MD
    Br J Clin Pharmacol; 2013 May; 75(5):1219-20. PubMed ID: 23297808
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicine versus the Medicare purse. Paying the price for prescription drugs.
    Kole LA
    JAAPA; 2000 Mar; 13(3):6, 9. PubMed ID: 11503404
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug spending: contribution to health care spending and cost containment strategies.
    Rivers PA; Hall NG; Frimpong J
    J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the availability and cost of medicines in the private sector in Mali].
    Maïga MD; Diawara A
    Med Trop (Mars); 2006 Dec; 66(6):565-8. PubMed ID: 17286022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.